Vifor Boosts US Nephrology Prospects With Janssen Pact

Vifor: Selling Invokana In DKD Could Aid Veltassa’s US sales

 
• By Sten Stovall
  
Kidney_Disease
J&J DKD pact lifts Vifor's nephrology portfolio to 12 products
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business